Coldstream Capital Management Inc Celldex Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 12 shares of CLDX stock, worth $243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$243% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
191Shares Held
66.5MCall Options Held
696KPut Options Held
519K-
Wellington Management Group LLP Boston, MA8.35MShares$170 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$132 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$95.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$79.1 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$76.2 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $949M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...